Immuneering (IMRX) Non-Current Assets: 2020-2024
Historic Non-Current Assets for Immuneering (IMRX) over the last 4 years, with Sep 2024 value amounting to $13.3 million.
- Immuneering's Non-Current Assets changed negligibly% to $13.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $13.3 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $13.5 million for FY2023, which is 0.88% down from last year.
- Immuneering's Non-Current Assets amounted to $13.3 million in Q3 2024, which was down 0.78% from $13.4 million recorded in Q2 2024.
- Immuneering's 5-year Non-Current Assets high stood at $14.4 million for Q4 2021, and its period low was $691,799 during Q4 2020.
- Over the past 3 years, Immuneering's median Non-Current Assets value was $13.4 million (recorded in 2024), while the average stood at $13.4 million.
- Per our database at Business Quant, Immuneering's Non-Current Assets soared by 1,977.31% in 2021 and then dropped by 5.22% in 2022.
- Over the past 5 years, Immuneering's Non-Current Assets (Quarterly) stood at $691,799 in 2020, then surged by 1,977.31% to $14.4 million in 2021, then dropped by 5.22% to $13.6 million in 2022, then fell by 0.88% to $13.5 million in 2023, then declined by 0.00% to $13.3 million in 2024.
- Its Non-Current Assets was $13.3 million in Q3 2024, compared to $13.4 million in Q2 2024 and $13.5 million in Q1 2024.